Latest Breaking News On - Lee rivas - Page 1 : vimarsana.com
Coliseum Capital challenges New Mountain Capital's $13.75/share offer for R1 RCM in an open letter to the Board. Despite a Q4 2023 revenue miss at $575.1 million, R1 RCM remains resilient with a break-even, strong EBITDA growth.
Lee-rivasColiseum-capital-managementNew-mountain-capital07.02.2024 - Top ranking for Ambulatory RCM Services, Government Reimbursement Services, and Underpayment Recovery Services underscores domain expertise and technology capabilitiesMURRAY, Utah, Feb. 07, 2024 (GLOBE NEWSWIRE) - R1 RCM Inc. (NASDAQ: RCM) (“R1”), . Seite 1
Lee-rivas